Effects of Taurine Supplementation on Growth in Low Birth Weight Infants: A Systematic Review and Meta-Analysis

Objective

To summarize the available randomized controlled trials (RCTs) to evaluate the effect of taurine supplementation on growth in low birth weight infants (LBW).

Methods

PubMed, EmBase, and Cochrane Library electronic databases were searched for published articles through March 2017. Analysis was done to examine the effect of taurine supplementation on growth, and sensitivity analysis was performed by removing each individual study from meta-analysis.

Results

Results of 9 trials totaling 216 LBW infants in the present meta-analysis were collected and analyzed. The conclusion of included studies demonstrated that taurine supplementation significantly reduced length gain (WMD:-0.18; P?<?0.001), plasma glycine (WMD:-106.71; P?=?0.033), alanine (WMD:-229.30; P?=?0.002), leucine (WMD:-64.76; P?<?0.001), tyrosine (WMD:-118.11; P?<?0.001), histidine (WMD:-52.16; P?<?0.001), proline (WMD: -84.29; P?=?0.033), and asparagine-glutamine (WMD:-356.30; P?<?0.001). However, taurine supplementation was associated with higher levels of acidic sterols (WMD:0.61; P?=?0.024), total fatty acids (WMD:7.94; P?=?0.050), total saturated fatty acids (WMD:9.70; P?<?0.001), and unsaturated fatty acids (WMD:6.63; P?<?0.001). Finally, taurine supplementation had little or no significant effect on weight gain, head circumference gain, plasma taurine, threonine, serine, citrulline, valine, methionine, isoleucine, phenylalanine, ornithine, lysine, arginine, glutamate, hydroxyproline, aspartate, dietary cholesterol, endogenous neutral sterols, cholesterol synthesis, and medium-chain triglycerides.

Conclusions

The findings suggest that although there are several significant differences in plasma indeces, no significant effect on growth in LBW infants was observed with taurine supplementation.